Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Neurology

Journal Scan / Research · May 14, 2020

Blood Phosphorylated tau 181 as a Biomarker for Alzheimer's Disease

The Lancet Neurology

 

Additional Info

The Lancet Neurology
Blood Phosphorylated tau 181 as a Biomarker for Alzheimer's Disease: A Diagnostic Performance and Prediction Modelling Study Using Data From Four Prospective Cohorts
Lancet Neurol 2020 May 01;19(5)422-433, TK Karikari, TA Pascoal, NJ Ashton, S Janelidze, AL Benedet, JL Rodriguez, M Chamoun, M Savard, MS Kang, J Therriault, M Schöll, G Massarweh, JP Soucy, K Höglund, G Brinkmalm, N Mattsson, S Palmqvist, S Gauthier, E Stomrud, H Zetterberg, O Hansson, P Rosa-Neto, K Blennow

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading